Analysis Corporate cannabis continues value brand pivot as Canada enters recession The bulk value category is trending up as legal players compete with Canada's still-thriving unregulated market Jared GnamJune 5, 2020
Analysis US House resolution points to war on drugs as contributing to police brutality Best way to reduce police violence is to scale back funding and amount of responsibility police have, says criminology prof Michelle GamageJune 2, 2020
Analysis ‘Huge chunk’ of Canada’s 383 weed companies won’t survive this year: investment banker Aaron Salz with Stoic Advisory sees a brutal year ahead for Canadian cannabis companies but brighter horizons in 2021 Jared GnamMay 15, 2020
Analysis Psychedelics are experiencing a renaissance, but don’t expect them to be legalized anytime soon Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say Michelle GamageMay 14, 2020
Analysis Outdoor cannabis licences almost double With production costs as low as $0.10 a gram in Canada, some analysts predict outdoor cultivation will disrupt legal weed Jared GnamMay 7, 2020
Analysis As cannabis bankruptcies accelerate during pandemic, lawyer says survivors will thrive long term Cannabis lawyer Ranjeev Dhillon remains optimistic for the longevity of the industry despite the pandemic-related market meltdown Jared GnamApril 8, 2020
Analysis No, cannabis isn’t recession proof, analyst says The recent COVID-19-related sales bump won't last as demand for cannabis isn't as inelastic during a recession as some think, Jerome Hass of Lightwater... Jared GnamApril 3, 2020
Analysis ‘Guys, we have one job: survive’ Analysis: Business professor says weed companies have to make tough decisions to survive the oncoming recession, as his did in the dot-com era Nick LabaApril 1, 2020